112 related articles for article (PubMed ID: 8112046)
1. In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers.
Murray PR; Jones RN; Washington JA; Gerlach EH; Allen SD
Diagn Microbiol Infect Dis; 1993; 17(4):307-11. PubMed ID: 8112046
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
Fuchs PC
Am J Med; 1991 Dec; 91(6A):15S-18S. PubMed ID: 1662886
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.
Gu JW; Fang W; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1992; 15(7):613-20. PubMed ID: 1330421
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
[TBL] [Abstract][Full Text] [Related]
9. Temafloxacin: in vitro comparison with five other antibacterial agents.
Digranes A; Hardardottir H; Bottolfsen KL
Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; MirĂ³ E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Sader HS; Erwin ME; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
[TBL] [Abstract][Full Text] [Related]
13. Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Forstall GJ; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1991 Aug; 35(8):1679-81. PubMed ID: 1656873
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Gooch G; Bodey GP
Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):684-6. PubMed ID: 3143585
[TBL] [Abstract][Full Text] [Related]
15. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
16. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
Jones RN; Pfaller MA;
Diagn Microbiol Infect Dis; 2001 Apr; 39(4):237-43. PubMed ID: 11404067
[TBL] [Abstract][Full Text] [Related]
17. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):12S-14S. PubMed ID: 1662881
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci.
Miranda AG; Wanger AR; Singh KV; Murray BE
Antimicrob Agents Chemother; 1992 Jun; 36(6):1325-8. PubMed ID: 1329621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]